SCHEMBL19759447

SCHEMBL19759447

CCc1c(C)nn(S(=O)(=O)c2ccc(C)cc2)c1C

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.53
MAPT P10636 3/20 0.51
MEN1 O00255 5/20 0.51
KMT2A Q03164 5/20 0.51
LMNA P02545 2/20 0.49
ALDH1A1 P00352 2/20 0.49
TDP1 Q9NUW8 1/20 0.49
HTT P42858 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
RAPGEF4 Q8WZA2 1/20 0.44
NR1H2 P55055 1/20 0.43
NR1H3 Q13133 1/20 0.43
TP53 P04637 3/20 0.43
THRB P10828 1/20 0.43
SLC9A1 P19634 1/20 0.42
GAA P10253 1/20 0.41
KDM4E B2RXH2 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17942372 0.86 POLB (0.52) POLBMAPTMEN1KMT2ALMNA
SCHEMBL1779195 0.79 POLB (0.46) POLBMAPTMEN1KMT2ALMNA
SCHEMBL12797057 0.78 POLB (0.53) POLBMAPTMEN1KMT2ALMNA
SCHEMBL5056157 0.78 POLB (0.56) POLBMAPTMEN1KMT2ALMNA
SCHEMBL5062898 0.76 POLB (0.55) POLBMAPTMEN1KMT2ALMNA
SCHEMBL28720779 0.76 POLB (0.70) POLBMAPTMEN1KMT2ALMNA
SCHEMBL17942309 0.75 LMNA (0.57) POLBMAPTMEN1KMT2ALMNA
SCHEMBL14678362 0.74 POLB (0.52) POLBMAPTMEN1KMT2ALMNA
SCHEMBL29596954 0.72 POLB (0.60) POLBMAPTMEN1KMT2ALMNA
SCHEMBL1224344 0.71 KMT2A (0.47) POLBMAPTMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180002343-A1 HETEROCYCLIC INHIBITORS OF MONOCARBOXYLATE TRANSPORTERS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED 2018-01-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180002343-A1 HETEROCYCLIC INHIBITORS OF MONOCARBOXYLATE TRANSPORTERS SLC16A1, SLC16A3, SLC16A7 POLB 3785/4885MAPT 1112/4885MEN1 322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.